Systemic immune markers and infection risk in preterm infants fed human milk fortified with bovine colostrum or conventional fortifier, a secondary analysis of the FortiColos trial.
- 2024-05-22
- RCT · n = 116
- Infection 52(6)
- Ole Bæk
- Tik Muk
- Lise Aunsholt
- Gitte Zachariasen
- Per Torp Sangild
- Duc Ninh Nguyen
- PubMed: 38775927
- DOI: 10.1007/s15010-024-02280-3
- High evidence
- Large Human Trial
- Clinical
infants fortified with BC showed more infection episodes (20 vs 12%, P < 0.05)
- Effect
- Harmful
- Effect size
- Moderate
- Significant
- Yes